Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay-Uwe Wagner

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|August 18, 2025
Platelet Jak2-deficiency accelerates atherosclerosis with increased inflammatory responseDaeun Kim, Yu Zhe Li, Jiaqi Yang, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
Molecular Cancer Therapeutics|July 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to EverolimusGabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, et al.
Iscience|March 27, 2023
Identification of actionable targets for breast cancer intervention using a diversity outbred mouse modelJennifer B Jacob, Kuang-Chung Wei, Gerold Bepler, et al.
The Journal of Biological Chemistry|January 26, 2012
Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intoleranceSally Yu Shi, Rubén García Martin, Robin E Duncan, et al.
Scientific Reports|August 11, 2017
Macrophage JAK2 deficiency protects against high-fat diet-induced inflammationHarsh R Desai, Tharini Sivasubramaniyam, Xavier S Revelo, et al.
Cancer Letters|September 25, 2024
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growthSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Hepatology (Baltimore, Md.)|July 5, 2011
Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in miceKristina M Mueller, Jan-Wilhelm Kornfeld, Katrin Friedbichler, et al.
The Journal of Clinical Investigation|December 3, 2011
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisRyan A Hlady, Slavomira Novakova, Jana Opavska, et al.
Scientific Reports|October 8, 2016
Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in MiceMadeleine Themanns, Kristina M Mueller, Sonja M Kessler, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|August 18, 2025
Platelet Jak2-deficiency accelerates atherosclerosis with increased inflammatory responseDaeun Kim, Yu Zhe Li, Jiaqi Yang, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
Molecular Cancer Therapeutics|July 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to EverolimusGabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, et al.
Iscience|March 27, 2023
Identification of actionable targets for breast cancer intervention using a diversity outbred mouse modelJennifer B Jacob, Kuang-Chung Wei, Gerold Bepler, et al.
The Journal of Biological Chemistry|January 26, 2012
Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intoleranceSally Yu Shi, Rubén García Martin, Robin E Duncan, et al.
Scientific Reports|August 11, 2017
Macrophage JAK2 deficiency protects against high-fat diet-induced inflammationHarsh R Desai, Tharini Sivasubramaniyam, Xavier S Revelo, et al.
Cancer Letters|September 25, 2024
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growthSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Hepatology (Baltimore, Md.)|July 5, 2011
Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in miceKristina M Mueller, Jan-Wilhelm Kornfeld, Katrin Friedbichler, et al.
The Journal of Clinical Investigation|December 3, 2011
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisRyan A Hlady, Slavomira Novakova, Jana Opavska, et al.
Scientific Reports|October 8, 2016
Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in MiceMadeleine Themanns, Kristina M Mueller, Sonja M Kessler, et al.
Pageof 13